SCHEMBL1633652

SCHEMBL1633652

CC(=O)NCCNc1ccc(-c2cc(F)cc3cnc(Nc4ccc(S(N)(=O)=O)cc4)nc23)cn1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NTRK1 P04629 1/20 0.43
CA2 P00918 9/20 0.43
CA1 P00915 7/20 0.43
CA9 Q16790 7/20 0.43
CA4 P22748 2/20 0.43
TDO2 P48775 1/20 0.42
CDK1 P06493 3/20 0.41
CCNT1 O60563 2/20 0.41
CDK2 P24941 2/20 0.41
CDK9 P50750 2/20 0.41
CCNB2 O95067 1/20 0.41
CCNE2 O96020 1/20 0.41
CCNB1 P14635 1/20 0.41
CCNE1 P24864 1/20 0.41
CDK5 Q00535 1/20 0.41
CDK5R1 Q15078 1/20 0.41
CCNB3 Q8WWL7 1/20 0.41
MAPK10 P53779 1/20 0.40
CA12 O43570 5/20 0.40
CA14 Q9ULX7 4/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13498265 0.93 NTRK1 (0.45) NTRK1CA2CA1CA9CA4
SCHEMBL1633211 0.88 MAPK10 (0.48) NTRK1CA2CA1CA9CA4
SCHEMBL1633507 0.87 NTRK1 (0.44) NTRK1CA2CA1CA9CA4
SCHEMBL1633573 0.83 CA1 (0.47) NTRK1CA2CA1CA9CA4
SCHEMBL1632926 0.82 CA2 (0.49) NTRK1CA2CA1CA9CA4
SCHEMBL1632804 0.81 NTRK1 (0.48) NTRK1CA2CA1CA9CA4
SCHEMBL1633663 0.80 NTRK1 (0.47) NTRK1CA2CA1CA9CA4
SCHEMBL1632508 0.79 MTOR (0.47) CDK1CDK2MAPK10IKBKB
SCHEMBL1632130 0.78 SYK (0.47) NTRK1CA2CA1CA9CA4
SCHEMBL13498354 0.77 MAPK10 (0.49) NTRK1CA2CA1CA9CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed